clotrimazole vaginal OTC
Selected indexed studies
- Clotrimazole. (, 2006) [PMID:30000270]
- Imidazoles for vaginitis. (Am Pharm, 1991) [PMID:1951030]
- Clinical and cost considerations in the pharmacotherapy of vulvovaginal candidiasis. (Pharmacoeconomics, 1996) [PMID:10160477]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Clotrimazole. (2006) pubmed
- Imidazoles for vaginitis. (1991) pubmed
- Clinical and cost considerations in the pharmacotherapy of vulvovaginal candidiasis. (1996) pubmed
- Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society. (2012) pubmed
- Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis). (2015) pubmed
- Physicians' perceptions of the impact of the reclassification of vaginal antifungal agents. (1994) pubmed
- A High Rate of Recurrent Vulvovaginal Candidiasis and Therapeutic Failure of Azole Derivatives Among Iranian Women. (2021) pubmed
- Impact of vaginal antifungal products on utilization of health care services: evidence from physician visits. (2000) pubmed
- Cross-Resistance of clinical isolates of Candida albicans and Candida glabrata to over-the-counter azoles used in the treatment of vaginitis. (2000) pubmed
- Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: I. Analyses of a unique database. (2004) pubmed